期刊
TRENDS IN BIOTECHNOLOGY
卷 23, 期 11, 页码 553-558出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2005.07.005
关键词
-
Some 160 biopharmaceuticals have now gained medical approval and several hundred are in the pipeline. Most are protein-based, although two nucleic acid-based products are now on the US/European market. An increasing proportion of approvals are engineered in some way and advances in alternative production systems and delivery methods will also likely impact upon the approvals profile over the remainder of this decade.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据